Cargando…
One‐year safety and efficacy study of bilastine treatment in Japanese patients with chronic spontaneous urticaria or pruritus associated with skin diseases
A number of second‐generation non‐sedating antihistamines are used in clinical practices over the world. However, long‐term safety and efficacy have not been proved high level evidence based medicine. We have performed an open‐label, multicenter, phase III study to evaluate the long‐term safety and...
Autores principales: | Yagami, Akiko, Furue, Masutaka, Togawa, Michinori, Saito, Akihiro, Hide, Michihiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412823/ https://www.ncbi.nlm.nih.gov/pubmed/27862227 http://dx.doi.org/10.1111/1346-8138.13644 |
Ejemplares similares
-
Bilastine for allergic rhinoconjunctivitis, urticaria
Publicado: (2022) -
The safety and tolerability profile of bilastine for chronic urticaria in children
por: Papadopoulos, Nikolaos G., et al.
Publicado: (2019) -
Pharmacokinetics, Pharmacodynamics and Population Pharmacokinetic/Pharmacodynamic Modelling of Bilastine, a Second-Generation Antihistamine, in Healthy Japanese Subjects
por: Togawa, Michinori, et al.
Publicado: (2016) -
Efficacy of switching to bilastine, a histamine H1 receptor antagonist, in patients with chronic spontaneous urticaria (H1-SWITCH): study protocol for a randomized controlled trial
por: Fukunaga, Atsushi, et al.
Publicado: (2020) -
Experience with bilastine in the management of urticaria: Original Real-world cases of Bilastine In Treatment (ORBIT) in Asia
por: Cheong, Wai Kwong, et al.
Publicado: (2022)